1. Home
  2. ENGLISH
  3. What we do
  4. BNCT clinical trials

BNCT clinical trials

Phase II clinical trials

The start dates are shown below for two phase II trials using a 10B compound formulation developed by Stella Pharma and an accelerator-based BNCT system created by Sumitomo Heavy Industries.

Phase II trial for recurrent malignant glioma December 2015
Phase II trial for head and neck cancer June 2016

World’s first BNCT trials

Recurrent malignant glioma
▷Phase II clinical trial started in December 2015

Head and neck cancer
▷Phase II clinical trial started in June 2016

Drug approval process